Novogene Stock Forecast for 2023 - 2025 - 2030
Updated on 05/18/2024
Novogene Stock Forecast and Price Target
Year-long price target forecasts from prominent analysts have recently been released for Novogene, with an average price target of ¥19.00. This potential gain of 32.04 percent from the previous closing price in May, 2024 is calculated on a high forecast of ¥28.75 and a low estimate of ¥16.70. If you're considering investing in 688315 stock, it's important to look at its competitors too.
32.04% Upside
Novogene Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Novogene has seen a decline in its Price, from ¥6.75 to ¥0.00 – a 100.00% decrease. For next year, analysts predict Fair Value of ¥0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that Novogene's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ERF Stock Forecast | Eurofins Scientific | Hold |
18
|
58.26€ | Buy/Sell | 0.00€ | 2.99% |
| 1548 Stock Forecast | Genscript Biotech | Buy |
5
|
HK$12.38 | Buy/Sell | HK$3.96 | -68.98% |
| AZTA Stock Forecast | Azenta | Hold |
16
|
$50.87 | Buy/Sell | $58.50 | 12.05% |
| TWST Stock Forecast | Twist Bioscience | Outperform |
4
|
$47.01 | Buy/Sell | $34.00 | -4.28% |
| 300676 Stock Forecast | BGI Genomics | - |
17
|
¥41.30 | Buy/Sell | ¥0.00 | -100.00% |
Novogene Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Novogene's Revenue has grown by 34.37%, rising from ¥1.49B to ¥2.00B. According to the 0 analysts polled, in the next year, Novogene's Revenue will fall by 9.02%, reaching ¥1.82B. By 2030, professionals believe that Novogene's Revenue will have decreased by 6.58%, falling to ¥1.87B.
.jpg)
Novogene Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Novogene's Dividend per Share has decreased by 16.67%, from ¥0.06 to ¥0.05. For next year, analysts predict Dividend per Share of ¥0.05, which would mean an increase of 6.67%. Over the next seven years, experts predict that Novogene's Dividend per Share will grow at a rate of 7.64%.
Novogene EBITDA Forecast for 2023 - 2025 - 2030
Novogene's EBITDA has grown In the last three years, rising from ¥140.26M to ¥298.44M – a growth of 112.78%. In the following year, 0 experts forecast Novogene's EBITDA will decrease by 16.85%, to ¥248.15M. In 2030, professionals predict that Novogene's EBITDA will decrease by 7.37%, to ¥276.45M.
Novogene EBIT Forecast for 2023 - 2025 - 2030
Novogene's EBIT has seen impressive growth In the last three years, rising from ¥33.62M to ¥176.97M – a growth of 426.38%. According to 0 major analysts, Novogene's EBIT will fall by 23.27% in the next year, reaching ¥135.79M. Professionals believe that By 2030, Novogene's EBIT will fall to ¥164.17M– a 7.23% decrease from its current value.
Novogene EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Novogene has seen a decline in its EPS, from ¥0.45 to ¥0.00 – a 100.00% decrease. For next year, analysts predict EPS of ¥0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that Novogene's EPS will grow at a rate of 100.00%.
.jpg)